Evidence map›Paper›PMID 34867954›Full record

ArticleFrontiers in immunology2021

JAK2-STAT Epigenetically Regulates Tolerized Genes in Monocytes in the First Encounter With Gram-Negative Bacterial Endotoxins in Sepsis.

Octavio Morante-Palacios, Clara Lorente-Sorolla, Laura Ciudad, Josep Calafell-Segura, Antonio Garcia-Gomez, Francesc Català-Moll, Adolfo Ruiz-Sanmartín, Mónica Martínez-Gallo, Ricard Ferrer, Juan Carlos Ruiz-Rodriguez and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Octavio Morante-PalaciosEpigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), Barcelona, Spain.
Clara Lorente-SorollaEpigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), Barcelona, Spain.
Laura CiudadEpigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), Barcelona, Spain.
Josep Calafell-SeguraEpigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), Barcelona, Spain.
Antonio Garcia-GomezEpigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), Barcelona, Spain.
Francesc Català-MollEpigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), Barcelona, Spain.
Adolfo Ruiz-SanmartínIntensive Care Department, Vall d'Hebron University Hospital, Shock, Organ Dysfunction and Resuscitation (SODIR) Research Group, Vall d' Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
Mónica Martínez-GalloImmunology Division, Vall d'Hebron University Hospital and Diagnostic Immunology Research Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.
Ricard FerrerIntensive Care Department, Vall d'Hebron University Hospital, Shock, Organ Dysfunction and Resuscitation (SODIR) Research Group, Vall d' Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
Juan Carlos Ruiz-RodriguezIntensive Care Department, Vall d'Hebron University Hospital, Shock, Organ Dysfunction and Resuscitation (SODIR) Research Group, Vall d' Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
Damiana Álvarez-ErricoEpigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), Barcelona, Spain.
Esteban BallestarEpigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), Barcelona, Spain.
Josep Carreras Leukaemia Research Institute · ESVall d'Hebron Institut de Recerca · ESUniversitat Autònoma de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbial challenges, such as widespread bacterial infection in sepsis, induce endotoxin tolerance, a state of hyporesponsiveness to subsequent infections. The participation of DNA methylation in this process is poorly known. In this study, we perform integrated analysis of DNA methylation and transcriptional changes following

Indexed as

Case-Control StudiesDNA MethylationEndotoxinsEndotoxin ToleranceEpigenesis, GeneticFemaleGram-Negative BacteriaGram-Negative Bacterial InfectionsHumansIn Vitro TechniquesJanus Kinase 2LipopolysaccharidesMaleMonocytesSepsisSignal TransductionEndotoxinsJAK2 protein, humanJanus Kinase 2LipopolysaccharidesSTAT Transcription FactorsTLR2 protein, humanTLR4 protein, humanToll-Like Receptor 2Toll-Like Receptor 4DNA methylationendotoxin toleranceJAK2monocytessepsisSTATsTET2tolerized genes

Identifiers

PMID34867954
PMCPMC8635809
OpenAlexW3212294567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.